Lisdexamphetamine versus methylphenidate for paediatric patients with attention-deficit hyperactivity disorder and type 1 diabetes (LAMAinDiab): protocol for a multicentre, randomised cross-over clinical trial in an outpatient telemedicine-supported setting.
BMJ Open
; 13(12): e078112, 2023 12 12.
Article
in En
| MEDLINE
| ID: mdl-38086595
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Attention Deficit Disorder with Hyperactivity
/
Diabetes Mellitus, Type 1
/
Central Nervous System Stimulants
/
Methylphenidate
Limits:
Adolescent
/
Child
/
Humans
Language:
En
Journal:
BMJ Open
Year:
2023
Document type:
Article
Affiliation country:
Polonia